T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Cable One
CABO
$191M
| $1.53B | 0.14% |
867,978
+48,916
| +6% | +$86.8M |
|
152
Mondelez International
MDLZ
$79.4B
| $1.52B | 0.14% |
22,993,953
+5,552,790
| +32% | +$343M |
|
|
SBNY
153
DELISTED
Signature Bank
SBNY
| $1.52B | 0.14% |
4,702,686
-382,236
| -8% | -$119M |
|
154
Western Alliance Bancorporation
WAL
$9.01B
| $1.51B | 0.14% |
14,063,679
+1,431,206
| +11% | +$161M |
|
155
MarketAxess Holdings
MKTX
$5.72B
| $1.51B | 0.14% |
3,668,968
+8,657
| +0.2% | +$3.41M |
|
156
Fortive
FTV
$18.6B
| $1.51B | 0.14% |
26,219,386
-1,381,627
| -5% | -$78.1M |
|
157
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.5B | 0.14% |
5,021,716
+108,916
| +2% | +$31.2M |
|
158
Hartford Financial Services
HIG
$37.7B
| $1.5B | 0.13% |
21,702,336
+2,255,762
| +12% | +$159M |
|
159
Expedia Group
EXPE
$39.1B
| $1.49B | 0.13% |
8,235,868
+3,988,070
| +94% | +$678M |
|
160
Equitable Holdings
EQH
$14.1B
| $1.48B | 0.13% |
45,033,655
+139,618
| +0.3% | +$4.58M |
|
161
Intercontinental Exchange
ICE
$85B
| $1.48B | 0.13% |
10,796,181
-187,811
| -2% | -$24.9M |
|
162
Public Service Enterprise Group
PEG
$37.8B
| $1.43B | 0.13% |
21,497,236
-507,828
| -2% | -$32.1M |
|
163
NXP Semiconductors
NXPI
$58.9B
| $1.43B | 0.13% |
6,266,352
-1,664,521
| -21% | -$354M |
|
164
CSX Corp
CSX
$92.8B
| $1.4B | 0.13% |
37,299,283
+12,301,193
| +49% | +$434M |
|
165
International Flavors & Fragrances
IFF
$21.4B
| $1.4B | 0.13% |
9,260,539
+1,701,318
| +23% | +$248M |
|
166
MSCI
MSCI
$40.9B
| $1.39B | 0.12% |
2,262,969
-847,456
| -27% | -$532M |
|
167
Starbucks
SBUX
$124B
| $1.37B | 0.12% |
11,754,128
-2,765,024
| -19% | -$312M |
|
168
American Tower
AMT
$79.4B
| $1.35B | 0.12% |
4,628,772
-518,766
| -10% | -$142M |
|
169
Charter Communications
CHTR
$17.9B
| $1.35B | 0.12% |
2,070,807
+450,091
| +28% | +$306M |
|
170
KKR & Co
KKR
$99.5B
| $1.34B | 0.12% |
17,992,626
-734,012
| -4% | -$54.2M |
|
171
Merck
MRK
$328B
| $1.33B | 0.12% |
17,304,803
-1,197,067
| -6% | -$95.3M |
|
172
Cooper Companies
COO
$15B
| $1.32B | 0.12% |
12,637,052
+45,516
| +0.4% | +$4.64M |
|
173
CMS Energy
CMS
$22B
| $1.32B | 0.12% |
20,224,988
+3,198,064
| +19% | +$196M |
|
174
Philip Morris
PM
$290B
| $1.31B | 0.12% |
13,762,999
-924,711
| -6% | -$86.4M |
|
175
Molina Healthcare
MOH
$10.8B
| $1.29B | 0.12% |
4,061,719
-6,058
| -0.1% | -$1.8M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.